PDB-code
Browse PDE entries (page 20 of 31)
First 16 17 18 PreviousLast24 23 22 Next| # | Species | PDE Type | PDB | Chain | Alternate Model | Ligand | Details | File |
|---|---|---|---|---|---|---|---|---|
 | Human | PDE4D | 1mkd | J | 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE |  | ||
| Human | PDE4D | 1mkd | K | 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE | | ||
| Human | PDE4D | 1mkd | L | 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE | | ||
| Human | PDE4D | 1oyn | A | A | ROLIPRAM | | |
| Human | PDE4D | 1oyn | A | B | ROLIPRAM | | |
| Human | PDE4D | 1oyn | B | A | ROLIPRAM | | |
| Human | PDE4D | 1oyn | B | B | ROLIPRAM | | |
| Human | PDE4D | 1oyn | C | A | ROLIPRAM | | |
| Human | PDE4D | 1oyn | C | B | ROLIPRAM | | |
| Human | PDE4D | 1oyn | D | A | ROLIPRAM | | |
| Human | PDE4D | 1oyn | D | B | ROLIPRAM | | |
| Human | PDE4D | 1ptw | A | ADENOSINEMONOPHOSPHATE | | ||
| Human | PDE4D | 1ptw | B | ADENOSINEMONOPHOSPHATE | | ||
| Human | PDE4D | 1ptw | C | ADENOSINEMONOPHOSPHATE | | ||
| Human | PDE4D | 1ptw | D | ADENOSINEMONOPHOSPHATE | | ||
| Human | PDE4D | 1q9m | A | ROLIPRAM | | ||
| Human | PDE4D | 1q9m | B | ROLIPRAM | | ||
| Human | PDE4D | 1q9m | C | ROLIPRAM | | ||
| Human | PDE4D | 1q9m | D | ROLIPRAM | | ||
| Human | PDE4D | 1tb7 | A | A | ADENOSINEMONOPHOSPHATE | | |
| Human | PDE4D | 1tb7 | A | B | ADENOSINEMONOPHOSPHATE | | |
| Human | PDE4D | 1tb7 | B | A | ADENOSINEMONOPHOSPHATE | | |
| Human | PDE4D | 1tb7 | B | B | ADENOSINEMONOPHOSPHATE | | |
| Human | PDE4D | 1tbb | A | A | ROLIPRAM | | |
| Human | PDE4D | 1tbb | A | B | ROLIPRAM | | |
| Human | PDE4D | 1tbb | A | C | | ||
| Human | PDE4D | 1tbb | B | A | ROLIPRAM | | |
| Human | PDE4D | 1tbb | B | B | ROLIPRAM | | |
| Human | PDE4D | 1tbb | B | C | | ||
| Human | PDE4D | 1xom | A | A | CILOMILAST | |
This research was performed as part of the "Phosphodiesterase inhibitors for neglected parasitic diseases" (PDE4NPD) programme, which is supported by the European Union 7th Framework Program (FP7/2007-2013) under grant agreement n° 602666.
